Table 2 Translocation breakpoint characteristics identified by MaReCs
Patient | Cytogenetic results | Number of embryos tested | Breakpoint location |
|---|---|---|---|
Patient 1 | 46,XX,t(2;5)(q14.2;p13.1) | 11 | chr2: 125,200,001 ± 200k; chr5: 35,500,001 ± 200k |
Patient 2 | 46,XY,t(13;17)(q11;q11.2) | 12 | chr13: 26,200,001 ± 200k; chr17: 34,000,001 ± 200k |